A specific HDAC6 inhibitor ameliorated Alzheimer’s disease phenotypes [48], and an HDAC8 inhibition repaired scopolamine-induced learning and memory impairments in animals [49]. This evidence concerns the gene HDAC6 and early-onset autosomal dominant Alzheimer disease.